CAJ | 학술논문

　　目的：探讨肺畅方对慢性阻塞性肺疾病稳定期伴抑郁患者的疗效。方法：采用前瞻性对照研究将64例重症肺炎患者简单随机分为治疗组和对照组，两组COPD规范治疗并合用黛力新抗抑郁，治疗组在此基础上加用肺畅方治疗，疗程为8周。结果：肺畅方及对照组在HAMD、SDS评分中均有显著降低，治疗组HAMD及SDS评分分别为（11.64±5.10）和（44.52±6.67），下降程度显著优于对照组（15.47±3.56）和（49.51±5.23），治疗组总有效率为89.67%（26/29），显效14例，有效12例，无效3例；明显高于对照组76.67%（23/30），显效10例，有效13例，无效7例。差异有统计学意义（P<0.05）。结论：在肺畅方对于改善COPD合并抑郁症患者的抑郁状态有良好的疗效，有较好的安全性。
　　목적：탐토폐창방대만성조새성폐질병은정기반억욱환자적료효。방법：채용전첨성대조연구장64례중증폐염환자간단수궤분위치료조화대조조，량조COPD규범치료병합용대력신항억욱，치료조재차기출상가용폐창방치료，료정위8주。결과：폐창방급대조조재HAMD、SDS평분중균유현저강저，치료조HAMD급SDS평분분별위（11.64±5.10）화（44.52±6.67），하강정도현저우우대조조（15.47±3.56）화（49.51±5.23），치료조총유효솔위89.67%（26/29），현효14례，유효12례，무효3례；명현고우대조조76.67%（23/30），현효10례，유효13례，무효7례。차이유통계학의의（P<0.05）。결론：재폐창방대우개선COPD합병억욱증환자적억욱상태유량호적료효，유교호적안전성。
Objective: To investigate the clinical effect of Feichang recipe on treating chronic obstructive pulmonary disease (COPD) combined with depression. Methods:64 cases of COPD accompanied with depression were randomly divided into treated group and control group. The patients of the treated group had been treated with Feichang recipe on the base of routine medicine treatment and flupentixol and melitracen tablets. The control group only received routine medicine treatment and flupentixol and melitracen tablets. The treatment course of 2 groups was 8weeks. Results:Both methods improve the HAMD score and SDS score, but the score of HAMD and SDS of treated group (11.64±5.10) and (44.52±6.67) were both lower significantly than that of control group (15.47±3.56) and (49.51± 5.23) (P<0.05). Conclusion:Feichang recipe had reasonable effect on COPD combined with depression.